# A Study to Learn About the Study Medicine Called PF-07328948 in Adults With Heart Failure (BRANCH-HF)

Study · id `cardio:ct-nct06991257` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT06991257](<https://clinicaltrials.gov/study/NCT06991257>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT06991257

Browse, organ or system: Heart  
Browse, condition area: Heart failure  

## In plain language

A phase 2 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 620 participants.

## Technical summary

Registry record NCT06991257. Randomized; quadruple masking; primary purpose treatment. Start 2025-06-19 (actual); primary completion 2028-05-08 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase: Phase 2
- Enrolled: 620 participants (planned count; ClinicalTrials.gov record NCT06991257, source copy `cardio:ctgov-nct06991257-2026-10-23`, retrieved 2026-10-26)
- Started: 2025-06-19 (actual) (ClinicalTrials.gov record NCT06991257, source copy `cardio:ctgov-nct06991257-2026-10-23`, retrieved 2026-10-26)
- Primary completion: 2028-05-08 (anticipated) (ClinicalTrials.gov record NCT06991257, source copy `cardio:ctgov-nct06991257-2026-10-23`, retrieved 2026-10-26)
- Completion: 2028-06-05 (anticipated) (ClinicalTrials.gov record NCT06991257, source copy `cardio:ctgov-nct06991257-2026-10-23`, retrieved 2026-10-26)
- Countries: United States; Argentina; Brazil; Bulgaria; Canada; China; Czechia; France; Hungary; Japan; Poland; Puerto Rico; Spain; United Kingdom (ClinicalTrials.gov record NCT06991257, source copy `cardio:ctgov-nct06991257-2026-10-23`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct06991257-2026-10-23`, retrieved 2026-10-26)

## The registry's words

- Brief title: A Study to Learn About the Study Medicine Called PF-07328948 in Adults With Heart Failure (BRANCH-HF)
- Condition: Heart Failure
- Intervention (Drug): Placebo
- Intervention (Drug): Low Dose PF-07328948
- Intervention (Drug): Medium Dose PF-07328948
- Intervention (Drug): High Dose PF-07328948
- Lead sponsor: Pfizer
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Heart failure (`cardio:heart-failure`)
- Registry lists this organization as the lead sponsor: Pfizer (`cardio:org-pfizer`)

## Provenance

Content hash: cccf48bd73e769e4831604c3f5b494198f29653fa6e74aba4c3c3bb032bcefd7
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
